Type II collagen (Col2a1) expression in all groups was also higher than the d0 level, but was significantly up-regulated with BMP6 treatment at 4 weeks compared to control OM (Fig. 7B; n = 6, p < 0.001). The gene discussed is BMP6; the disease is ocular melanoma.